Go to content
- {{#headlines}}
- {{title}} {{/headlines}}
Profile
| Academic position | Full Professor |
|---|---|
| Research fields | Metabolism, Biochemistry, and Genetics of Microorganisms |
| Keywords | Mycobacteria tuberculosis, microbial genomics, molecular pathogenesis, genetic polymorphism, epidemiology |
| Honours and awards | : Elected Fellow, American Academy of Microbiology, Washington, USA : Elected Fellow, TWAS, Trieste, Italy : Germany’s Highest Civilian Award- The Order of Merit (Das Verdienstkreuz, 1.Klasse) : Humboldt Prize, AvH Foundation, Germany : India's Civilian Award, Padma Shri : JC Bose National Fellow, India : Member German National Academy of Sciences, Leopoldina, Germany : National Science Chair, India : Robert Koch Fellow, Robert Koch Institute, Berlin : SS Bhatnagar Prize, India : The Ambedkar Award for BioMedical Sciences, ICMR, India |
Current contact address
| Country | India |
|---|---|
| City | South West Delhi |
| Institution | Jamia Hamdard University |
| Institute | Institute of Molecular Medicine |
| Homepage | http://en.wikipedia.org/wiki/Seyed_E._Hasnain |
Host during sponsorship
| Prof. Dr. Jörg Hacker | Robert Koch-Institut (RKI), Berlin |
|---|---|
| Prof. Dr. Ulrich Dobrindt | Institut für Molekulare Infektionsbiologie, Julius-Maximilians-Universität Würzburg, Würzburg |
| Prof. Dr. Jörg Hacker | Leopoldina - Nationale Akademie der Wissenschaften, Halle (Saale) |
| Prof. Dr. Lothar H. Wieler | Robert Koch-Institut (RKI), Berlin |
| Start of initial sponsorship | 01/07/2008 |
Programme(s)
| 2008 | Humboldt Research Award Programme |
|---|
Nominator's project description
| Professor Hasnain is well known internationally for his outstanding research on the analyses of infectious diseases due to bacteria. He has made important contributions to the pathogenicity and epidemiology of Mycobacterium tuberculosis. Beside the development of methods to rapidly detect and type bacterial pathogens, especially mycobacteria, he identified new antigenic substances of M. tuberculosis which represent promising vaccine candidates against mycobacteria. In Germany, he continues his research on the population structure and genome content of pathogenic bacteria, especially Escherichia coli and staphylocci. |